Immunodominant epitope in the C-terminus of a variable major protein in Borrelia duttonii, an agent of tick-borne relapsing fever

Microbiology and Immunology
Norihiko TabuchiMasahito Fukunaga

Abstract

Borrelia duttonii strain Ly was isolated from a child with tick-borne relapsing fever in Tanzania. B. duttonii produces variable major proteins (Vmps), which undergo antigenic variation. We previously reported transcription of the vmpP gene, which is one of the Vmp genes in strain Ly, detected in vitro cultivation. In the current study, we purified the recombinant non-lipidated VmpP protein by affinity chromatography and produced VmpP polyclonal antibodies. Antigenicity of VmpP was examined by Western immunoblot analysis and peptide-based enzyme-linked immunosorbent assays. Antigenic epitopes were shown to comprise five regions interspersed within the VmpP primary amino acid sequence. Synthetic peptides spanning residues of three of five regions, 232-237 (LASIVD), 280-285 (AGGIAL), and 350-355 (KAADQQ), reacted strongly with the VmpP-specific antibody and these residues were identified as epitopes. In particular, the C-terminal domain (KAADQQ) of this protein was immunoreactive. Further research based on our results will promote the development of a recombinant vaccine for B. duttonii infection.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Nov 1, 1992·Molecular Microbiology·B I RestrepoA G Barbour
Jan 1, 1990·Annual Review of Microbiology·A G Barbour
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T Kitten, A G Barbour
Jun 1, 1985·The Journal of Experimental Medicine·P A BarstadA G Barbour
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T P Hopp, K R Woods
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·E FikrigR A Flavell
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·H LiC L Lawson
May 30, 1998·Microbial Pathogenesis·H KawabataH Watanabe
Nov 18, 1998·Journal of Clinical Microbiology·M J MathiesenM Theisen
Dec 23, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·A TalbertF Molteni
Nov 11, 1999·International Journal of Systematic Bacteriology·S J CutlerD A Warrell
Aug 23, 2000·The Journal of Clinical Investigation·U PalE Fikrig
Sep 22, 2000·Emerging Infectious Diseases·A G Barbour, B I Restrepo
Jan 15, 2001·The Journal of Biological Chemistry·C EickenJ C Sacchettini
Feb 28, 2001·Microbiology and Immunology·Y TakahashiM Fukunaga
Mar 30, 2002·The Journal of Biological Chemistry·Christoph EickenJames C Sacchettini
Jun 26, 2003·Nucleic Acids Research·Torsten SchwedeManuel C Peitsch
Feb 17, 2005·The Journal of Biological Chemistry·Michael BeckerCatherine L Lawson
May 11, 2005·Vaccine·Eric L BrownMagnus Höök

❮ Previous
Next ❯

Citations

Sep 3, 2010·Nihon saikingaku zasshi. Japanese journal of bacteriology·Masahito Fukunaga, Norihiko Tabuchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.